Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, includ...
Q1 2026
Feb 9, 2026
FY 2025
Nov 25, 2025
Q4 2025
Q3 2025
Aug 12, 2025
Q2 2025
May 13, 2025